**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 43036-06-2 |N-(2-Cyanoethyl)pyrrole | >99 | 256-051-6 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and in contact with skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if
swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
May be metabolized to cyanide which in turn acts by inhibiting
cytochrome oxidase impairing cellular respiration. Chronic exposure
to cyanide solutions may lead to the development of a "cyanide" rash,
characterized by itching, and by macular, papular, and vesicular
eruptions, and may be accompanied by secondary infections. Exposure
to small amounts of cyanide compounds over long periods of time is
reported to cause loss of appetite, headache, weakness, nausea,
dizziness, and symptoms of irritation of the upper respiratory tract
and eyes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Vapors may be heavier
than air. They can spread along the ground and collect in low or
confined areas. Containers may explode when heated.
Extinguishing Media:
Do NOT get water inside containers. For small fires, use dry
chemical, carbon dioxide, or water spray. For large fires, use dry
chemical, carbon dioxide, alcohol-resistant foam, or water spray.
Cool containers with flooding quantities of water until well after
fire is out.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Provide
ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 43036-06-2:
Personal Protective Equipment
Eyes:
Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear yellow
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 132-133 deg C @ 10 mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: > 112 deg C (> 233.60 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 1.0480g/cm3
Molecular Formula: C7H8N2
Molecular Weight: 120.15
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Hydrogen cyanide, carbon monoxide, oxides of nitrogen, carbon
dioxide.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 43036-06-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-(2-Cyanoethyl)pyrrole -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2810
Packing Group: I
IMO
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: I
RID/ADR
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing group: I
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21 Harmful by inhalation and in contact with
skin.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 43036-06-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 43036-06-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 43036-06-2 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #5 Date: 4/22/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
1-(2,3-Dihydrobenzo[b]furan-5-yl)ethan-1-one, 97%
| 90843-31-5 |
|
alpha-Terpinene, tech. 85-90%
| 99-86-5 |
|
3-Acetyl-1,3-thiazolane-2-carbohydrazide, 97%
| 175203-18-6 |
|
1-Bromo-2-(2-chloroethoxy)-3,5-difluorobenzene, 97%
| 175203-19-7 |
|
5,7-Difluoro-2,3-dihydrobenzo[b]furan, 97%
| 175203-20-0 |
|
Ethyl 2-mercapto-1H-imidazole-4-carboxylate, 97%
| 64038-64-8 |
|
5-({[5-(Trifluoromethyl)-2-pyridyl]thio}methyl)-2-furoic acid, 97%
| 238742-86-4 |
|
3-(2-Methyl-3-furyl)-3-oxopropanenitrile, 97%
| 158386-97-1 |
|
4-Fluoro-2-nitrobenzonitrile, 97%
| 80517-21-1 |
|
Methyl 3-[(4-bromo-3,5-dimethyl-1h-pyrazol-1-yl)methyl]benzoate, 97%
| 175203-23-3 |
|
3-[(4-Bromo-3,5-dimethyl-1h-pyrazol-1-yl)methyl]benzoic acid, 97%
| 175203-24-4 |
|
N4-(2-hydrazino-2-oxoethyl)-2,1,3-benzothiadiazole-4-sulfonamide, 97%
| 175203-26-6 |
|
4-Bromo-2-nitroaniline, 97%
| 875-51-4 |
|
2-[(2,4-Dichlorophenyl)sulfonyl]acetonitrile, 97%
| 87475-64-7 |
|
2-Fluoro-6-[4-(methylthio)phenoxy]benzonitrile, 97%
| 148901-52-4 |
|
2,4-Dichloro-1-[(2-chloroethyl)sulfonyl]benzene, 97%
| 175203-30-2 |
|
N1-phenylbenzene-1-carboximidamide, 97%
| 1527-91-9 |
|
4-[(1,1-Dimethylprop-2-ynyl)oxy]benzonitrile, 97%
| 33143-92-9 |
|
2,2-Dimethyl-2h-chromene-6-carbonitrile, 97%
| 33143-29-2 |
|
5-Chloro-4-nitro-2,1,3-benzothiadiazole, 97%
| 2274-89-7 |
|
2-[(2-Phenoxyethyl)thio]acetic acid, 97%
| 75434-70-7 |
|
1-(3,4-Dimethoxyphenyl)ethan-1-one oxime, 97%
| 88920-78-9 |
|
5-Chloro-2,1,3-benzoxadiazole, 95+%
| 19155-86-3 |
|
2,1,3-Benzoxadiazole-5-carbonitrile, 97%
| 54286-62-3 |
|
3-[({[1-(3,4-Dichlorophenyl)ethylidene]amino}oxy)methyl]benzoic acid,
| 175203-32-4 |
|
3-[({[1-(4-Chlorophenyl)ethylidene]amino}oxy)methyl]benzoic acid, 97%
| 175203-33-5 |
|
4,4'-Dimethoxybenzophenone, 97%
| 90-96-0 |
|
2-(Methylthio)-6-nitro-1,3-benzothiazole, 97%
| 3621-99-6 |
|
2,1,3-Benzoxadiazole-5-carbothioamide, 97%
| 306935-24-0 |
|
5-Nitrovanillin, 99%
| 6635-20-7 |
|
Ethyl 2-(3-thioxo-3,4-dihydro-2h-1,4-benzothiazin-2-yl)acetate, 97%
| 2832-87-3 |
|
2,1,3-Benzoxadiazol-5-ol, 97%
| 768-09-2 |
|
N-(2-Cyanoethyl)pyrrole, 99+%
| 43036-06-2 |
|
2-(3-Oxo-1,3-dihydroisobenzofuran-1-yliden)acetic acid, 97%
| 4743-57-1 |
|
Trans-2-Hepten-1-Ol, 99+%
| 33467-76-4 |
|
2-(Methylthio)-1,3-benzothiazol-6-amine, 97%
| 25706-29-0 |
|
2-(4-Oxo-3,4-dihydrophthalazin-1-yl)acetic acid, 95+%
| 25947-11-9 |
|
6-(Bromomethyl)-4-chloro-2-(trifluoromethyl)quinoline, 95+%
| 123637-51-4 |
|
4-Chloro-8-(trifluoromethoxy)-2-(trifluoromethyl)quinoline,97%
| 306935-27-3 |
|
Diethyl 1,2,3,6-tetrahydropyridazine-1,2-dicarboxylate, 97%
| 35691-30-6 |
|
5,7-Dichloro-2-(trifluoromethyl)quinolin-4-ol, 97%
| 59108-13-3 |
|
4,5,7-Trichloro-2-(trifluoromethyl)quinoline, 97%
| 175203-41-5 |
|
7-Chloro-2-(trifluoromethyl)quinolin-4-ol, 97%
| 57124-20-6 |
|
5-[(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-2-furoic acid, 97%
| 306935-28-4 |
|
4-Chloro-2-(trifluoromethyl)quinoline, 97%
| 1701-24-2 |
|
Methyl 2-{[2-(trifluoromethyl)-4-quinolyl]thio}acetate, 97%
| 175203-42-6 |
|
2-Methylbenzhydrol, 98+%
| 5472-13-9 |
|
2-{[2-(trifluoromethyl)-4-quinolyl]thio]ethanohydrazide, 95+%
| 175203-43-7 |
|
Difurfuryldisulfide, 96%
| 4437-20-1 |
|
Ethyl N-(2-cyano-3-ethoxyacryloyl)carbamate, 97%
| 1187-34-4 |
|
|